| Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open … BK Koo, J Kang, KW Park, TM Rhee, HM Yang, KB Won, SW Rha, JW Bae, ... The Lancet 397 (10293), 2487-2496, 2021 | 212 | 2021 |
| CD82/KAI1 maintains the dormancy of long-term hematopoietic stem cells through interaction with DARC-expressing macrophages J Hur, JI Choi, H Lee, P Nham, TW Kim, CW Chae, JY Yun, JA Kang, ... Cell stem cell 18 (4), 508-521, 2016 | 157 | 2016 |
| Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open … HS Kim, J Kang, D Hwang, JK Han, HM Yang, HJ Kang, BK Koo, JY Rhew, ... The Lancet 396 (10257), 1079-1089, 2020 | 148 | 2020 |
| Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized … JM Lee, J Park, J Kang, KH Jeon, J Jung, SE Lee, JK Han, HL Kim, ... JACC: Cardiovascular Interventions 8 (3), 382-394, 2015 | 126 | 2015 |
| Racial differences in ischaemia/bleeding risk trade-off during anti-platelet therapy: individual patient level landmark meta-analysis from seven RCTs J Kang, KW Park, T Palmerini, GW Stone, MS Lee, A Colombo, A Chieffo, ... Thrombosis and haemostasis 119 (01), 149-162, 2019 | 120 | 2019 |
| Coronary protection to prevent coronary obstruction during TAVR: a multicenter international registry T Palmerini, T Chakravarty, F Saia, AG Bruno, ML Bacchi-Reggiani, ... Cardiovascular Interventions 13 (6), 739-747, 2020 | 68 | 2020 |
| Fractional flow reserve or intravascular ultrasonography to guide PCI BK Koo, X Hu, J Kang, J Zhang, J Jiang, JY Hahn, CW Nam, JH Doh, ... New England Journal of Medicine 387 (9), 779-789, 2022 | 65 | 2022 |
| Chronic kidney disease in the second-generation drug-eluting stent era: pooled analysis of the Korean multicenter drug-eluting stent registry JM Lee, J Kang, E Lee, D Hwang, TM Rhee, J Park, HL Kim, SE Lee, ... Cardiovascular Interventions 9 (20), 2097-2109, 2016 | 65 | 2016 |
| The evolving concept of dual antiplatelet therapy after percutaneous coronary intervention: focus on unique feature of East Asian and “Asian Paradox” J Kang, HS Kim Korean Circulation Journal 48 (7), 537, 2018 | 63 | 2018 |
| Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study J Kang, KW Park, H Lee, D Hwang, HM Yang, SW Rha, JW Bae, NH Lee, ... Circulation 147 (2), 108-117, 2023 | 57 | 2023 |
| Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis J Lee, S Hahn, DW Kim, J Kim, SN Kang, SY Rha, KB Lee, JH Kang, ... British journal of cancer 108 (1), 39-48, 2013 | 52 | 2013 |
| P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events F Gragnano, D Cao, L Pirondini, A Franzone, HS Kim, M von Scheidt, ... Journal of the American College of Cardiology 82 (2), 89-105, 2023 | 49 | 2023 |
| Focused update of 2016 Korean Society of Heart Failure guidelines for the management of chronic heart failure KJ Kim, HJ Cho, MS Kim, J Kang, KH Kim, D Kim, SM Seo, JH Yang, ... International Journal of Heart Failure 1 (1), 4, 2019 | 49 | 2019 |
| Third-generation P2Y12 inhibitors in East Asian acute myocardial infarction patients: a nationwide prospective multicentre study J Kang, JK Han, Y Ahn, SC Chae, YJ Kim, I Chae, SH Hur, IW Seong, ... Thrombosis and Haemostasis 118 (03), 591-600, 2018 | 47 | 2018 |
| Genetic determinants of clopidogrel responsiveness in Koreans treated with drug-eluting stents JJ Park, KW Park, J Kang, KH Jeon, SH Kang, HS Ahn, JK Han, JS Koh, ... International journal of cardiology 163 (1), 79-86, 2013 | 46 | 2013 |
| Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention KW Park, J Kang, JJ Park, HM Yang, HY Lee, HJ Kang, BK Koo, BH Oh, ... Heart 98 (18), 1366-1372, 2012 | 45 | 2012 |
| Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of ‘smokers’ paradox' KW Park, SH Kang, J Kang, KH Jeon, JJ Park, JK Han, JS Koh, SE Lee, ... Heart 98 (13), 1000-1006, 2012 | 45 | 2012 |
| The effects of erythropoiesis stimulating therapy for anemia in chronic heart failure: a meta-analysis of randomized clinical trials J Kang, J Park, JM Lee, JJ Park, DJ Choi International journal of cardiology 218, 12-22, 2016 | 43 | 2016 |
| The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in … KW Park, J Kang, SH Kang, HS Ahn, HJ Kang, BK Koo, IH Chae, TJ Youn, ... American heart journal 167 (3), 384-392. e5, 2014 | 43 | 2014 |
| Predictors and Prognostic Value of Worsening Renal Function During Admission in HF p EF Versus HF r EF: Data From the Kor AHF (Korean Acute Heart Failure) Registry J Kang, JJ Park, YJ Cho, IY Oh, HA Park, SE Lee, MS Kim, HJ Cho, ... Journal of the American Heart Association 7 (6), e007910, 2018 | 42 | 2018 |
